Frequently Asked Questions

This is absolutely impossible, since there is less than 0.1% THC, being the psychoactive substance from the hemp plant, in the MariPharm CBD oil.

Click here for an analysis certificate of the MariPharm CBD oil.

The psychoactive substance from the hemp plant is THC, this is the substance that one experiences a “stoned” or “high” feeling of. CBD, on the other hand, is not psychoactive and can therefore, unlike THC, be sold without a prescription (via the pharmacy).

Unlike many other CBD products, the MariPharm CBD products contain less than 0.01% THC. MariPharm can guarantee this low THC percentage, since it is the only CBD producer that has an Opium exemption for scientific purposes, produced by the Ministry of Health, Welfare and Sport.

This allows MariPharm to have its CBD oil analyzed in its own and external laboratories for THC content.

Gezien het feit dat CBD geen geregistreerd medicijn is, mag er maar in beperkte mate informatie over het product worden verstrekt.

Indien u antwoorden op persoonlijke vragen zou willen omtrent het gebruik van CBD, dan adviseren wij u om via deze link contact met ons op te nemen.

The recommended daily dose of MariPharm CBD oil is 3 times 3 drops per day. If you still want to try a higher dose (try it out), then we advise you to do this in consultation with your doctor.

The best way to take CBD oil is 3 times a day, 5 minutes after the meal (breakfast, lunch and dinner). Hold the drops under your tongue for about 10 seconds and then take a few gulps of water.

It is best to store the CBD oil at room temperature and especially in a dark place.

The regulations regarding CBD oil are different in (almost) every country. For customized advice you can contact us via this link.

In case of complaints about the ordered product, you can contact MariPharm via info@maripharm.com, or consult the general terms and conditions (art. 16 paragraph F), or, after the expiry of 4 weeks (intended for mutual consultation between MariPharm and you), submit your complaint on the ODR platform via the following link: http://ec.europa.eu/odr.